The NeuroStar Difference
The NeuroStar® Difference NeuroStar® Advanced Therapy is an FDA-cleared, non-drug, non-invasive treatment for people suffering from depression who are not satisfied with the results of antidepressant medications. Proven safe, proven effective, and proven to transform lives, NeuroStar is backed by the most robust service, support, and marketing in the industry.10,14
Awareness & Access
Neuronetics invested $14.5 million in marketing in 2022 which resulted in 33% increase in brand awareness. We use industry-unique programs like our Precision Pulse Program to partner with our practices as we work together to grow their awareness.
5-STARS to Success
Based on 12 years of experience and 1,100 NeuroStar practices, our 5-STARS to Success program is a proven formula to help grow NeuroStar practices by transforming the lives of people with depression. 5-STARS to Success helps NeuroStar doctors identify ideal patients, increase patient awareness, and market their practice. The average 5-STARS practice generates over $300,000 in revenue.
Comprehensive Sales & Support Teams
NeuroStar has the largest direct sales force and customer support team in the industry. In addition to helping more and more patients find lasting remission from the symptoms of depression, these individuals lay the foundation for lifetime partnerships with each of our customers.
We help our practices operationalize and grow their NeuroStar service line. We provide step-by-step practice implementation, staff training, and management planning services. We offer a wide range of marketing support, assistance with insurance reimbursement, and 24/7 technical support and field service.
Market Leader
NeuroStar is the leading TMS treatment for major depressive disorder. Precisely targeted NeuroStar Advanced Therapy makes long-term remission6,9 from depression symptoms possible—which is why it’s the top TMS choice of doctors nationwide, with over 6.6 million treatments delivered.
Substantial Clinical Data
The safety and efficacy of NeuroStar is backed by the largest clinical data set of any TMS system for depression.1 Two large, multisite, randomized, controlled trials demonstrated the clinically significant antidepressant effect of NeuroStar Advanced Therapy.9,15 NeuroStar efficacy was also demonstrated in a multisite, real-world, open-label clinical trial in which patients received an acute treatment course of NeuroStar Advanced Therapy.3
Largest Real-World Outcomes Registry
Only NeuroStar has the world’s largest depression Outcomes Registry**. By clinician rating, 83% of patients responded to an acute course of NeuroStar, and 62% achieved remission.3,18
Proprietary Technology
NeuroStar is based on a broad intellectual property portfolio. Our technologies have taken TMS therapy to a new level through a patented delivery process that optimizes the treatment process—from measuring the most appropriate dose (MT Assist®), to ensuring consistent and repeatable pulse delivery (Contact Sensing), to providing secure, HIPAA-compliant patient data management (TrakStar®).
Wide Insurance Reimbursement
NeuroStar is widely reimbursed, with insurance coverage in all 50 states, including Medicare and Tricare. Over 95 major U.S. private insurers provide coverage policies for NeuroStar, representing 300 million people with coverage.1 Medicare provides 100% coverage (61 million covered people).
Learn More
For more information on the NeuroStar difference, how to join our team, or ways you can invest in our future, contact Neuronetics today.
Contact Neuronetics